Privia Health Group, Inc. Increase (Decrease) in Accounts Receivable
Privia Health Group, Inc. (PRVA) reported Increase (Decrease) in Accounts Receivable of $172.38 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsReceivable · last filed 2026-08-06
- Privia Health Group, Inc. increase (decrease) in accounts receivable for the quarter ending 2026-06-30 was $59.60M, a 21.77% increase year-over-year.
- Privia Health Group, Inc. increase (decrease) in accounts receivable for the quarter ending 2026-03-31 was $112.77M, a 55.45% increase year-over-year.
- Privia Health Group, Inc. increase (decrease) in accounts receivable for the quarter ending 2025-12-31 was -$139.88M.
- Privia Health Group, Inc. increase (decrease) in accounts receivable for the quarter ending 2025-09-30 was $55.05M, a 41.49% increase year-over-year.
- Privia Health Group, Inc. increase (decrease) in accounts receivable for fiscal 2025 was $36.67M, a 84.97% increase from fiscal 2024.
- Privia Health Group, Inc. increase (decrease) in accounts receivable for fiscal 2024 was $19.82M, a 79.54% decline from fiscal 2023.
- Privia Health Group, Inc. increase (decrease) in accounts receivable for fiscal 2023 was $96.88M, a 34.17% increase from fiscal 2022.
- Privia Health Group, Inc. increase (decrease) in accounts receivable for fiscal 2022 was $72.20M, a 393.12% increase from fiscal 2021.
| Period end | Increase (Decrease) in Accounts Receivable 3 month | Increase (Decrease) in Accounts Receivable 6 month | Increase (Decrease) in Accounts Receivable 9 month | Increase (Decrease) in Accounts Receivable 12 month |
|---|---|---|---|---|
| 2026-06-30 | $59.60M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $172.38M 10-Q · filed 2026-08-06 | $32.50M derived: sum of 3 quarters · filed 2026-08-06 | $87.55M derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | $112.77M 10-Q · filed 2026-05-07 | -$27.10M derived: sum of 2 quarters · filed 2026-05-07 | $27.95M derived: sum of 3 quarters · filed 2026-05-07 | $76.89M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | -$139.88M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | -$84.83M derived: sum of 2 quarters · filed 2026-02-27 | -$35.88M derived: sum of 3 quarters · filed 2026-08-06 | $36.67M 10-K · filed 2026-02-27 |
| 2025-09-30 | $55.05M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $104.00M derived: sum of 2 quarters · filed 2026-08-06 | $176.54M 10-Q · filed 2025-11-06 | $78.18M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | $48.95M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $121.50M 10-Q · filed 2026-08-06 | $23.13M derived: sum of 3 quarters · filed 2026-08-06 | $62.03M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | $72.55M 10-Q · filed 2026-05-07 | -$25.82M derived: sum of 2 quarters · filed 2026-05-07 | $13.09M derived: sum of 3 quarters · filed 2026-05-07 | $37.05M derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | -$98.37M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | -$59.46M derived: sum of 2 quarters · filed 2026-02-27 | -$35.50M derived: sum of 3 quarters · filed 2026-02-27 | $19.82M 10-K · filed 2026-02-27 |
| 2024-09-30 | $38.90M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $62.87M derived: sum of 2 quarters · filed 2025-11-06 | $118.19M 10-Q · filed 2025-11-06 | $58.85M derived: sum of 4 quarters · filed 2026-02-27 |
| 2024-06-30 | $23.97M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | $79.29M 10-Q · filed 2025-08-07 | $19.95M derived: sum of 3 quarters · filed 2026-02-27 | $45.93M derived: sum of 4 quarters · filed 2026-02-27 |
| 2024-03-31 | $55.32M 10-Q · filed 2025-05-08 | -$4.02M derived: sum of 2 quarters · filed 2026-02-27 | $21.96M derived: sum of 3 quarters · filed 2026-02-27 | $80.92M derived: sum of 4 quarters · filed 2026-02-27 |
| 2023-12-31 | -$59.34M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | -$33.36M derived: sum of 2 quarters · filed 2026-02-27 | $25.60M derived: sum of 3 quarters · filed 2026-02-27 | $96.88M 10-K · filed 2026-02-27 |
| 2023-09-30 | $25.98M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $84.94M derived: sum of 2 quarters · filed 2024-11-07 | $156.22M 10-Q · filed 2024-11-07 | $99.47M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-06-30 | $58.96M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | $130.24M 10-Q · filed 2024-08-08 | $73.49M derived: sum of 3 quarters · filed 2025-02-27 | $105.95M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-03-31 | $71.28M 10-Q · filed 2024-05-09 | $14.53M derived: sum of 2 quarters · filed 2025-02-27 | $46.99M derived: sum of 3 quarters · filed 2025-02-27 | $94.64M derived: sum of 4 quarters · filed 2025-02-27 |
| 2022-12-31 | -$56.74M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | -$24.29M derived: sum of 2 quarters · filed 2025-02-27 | $23.37M derived: sum of 3 quarters · filed 2025-02-27 | $72.20M 10-K · filed 2025-02-27 |
| 2022-09-30 | $32.46M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-03 | $80.11M derived: sum of 2 quarters · filed 2023-11-03 | $128.95M 10-Q · filed 2023-11-03 | $144.32M derived: sum of 4 quarters · filed 2024-02-27 |
| 2022-06-30 | $47.65M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03 | $96.49M 10-Q · filed 2023-08-03 | $111.86M derived: sum of 3 quarters · filed 2024-02-27 | $83.38M derived: sum of 4 quarters · filed 2024-02-27 |
| 2022-03-31 | $48.84M 10-Q · filed 2023-05-04 | $64.21M derived: sum of 2 quarters · filed 2024-02-27 | $35.72M derived: sum of 3 quarters · filed 2024-02-27 | $45.88M derived: sum of 4 quarters · filed 2024-02-27 |
| 2021-12-31 | $15.38M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-27 | -$13.11M derived: sum of 2 quarters · filed 2024-02-27 | -$2.96M derived: sum of 3 quarters · filed 2024-02-27 | $14.64M 10-K · filed 2024-02-27 |
| 2021-09-30 | -$28.49M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | -$18.34M derived: sum of 2 quarters · filed 2022-11-10 | -$734.00K 10-Q · filed 2022-11-10 | $10.91M derived: sum of 4 quarters · filed 2023-03-01 |
| 2021-06-30 | $10.15M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11 | $27.75M 10-Q · filed 2022-08-11 | $39.40M derived: sum of 3 quarters · filed 2023-03-01 | $28.88M derived: sum of 4 quarters · filed 2023-03-01 |
| 2021-03-31 | $17.60M 10-Q · filed 2022-05-12 | $29.24M derived: sum of 2 quarters · filed 2023-03-01 | $18.73M derived: sum of 3 quarters · filed 2023-03-01 | $24.48M derived: sum of 4 quarters · filed 2023-03-01 |
| 2020-12-31 | $11.64M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | $1.13M derived: sum of 2 quarters · filed 2023-03-01 | $6.88M derived: sum of 3 quarters · filed 2023-03-01 | $21.78M 10-K · filed 2023-03-01 |
| 2020-09-30 | -$10.51M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-08 | -$4.76M derived: sum of 2 quarters · filed 2021-11-08 | $10.14M 10-Q · filed 2021-11-08 | |
| 2020-06-30 | $5.75M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-09 | $20.65M 10-Q · filed 2021-08-09 | ||
| 2020-03-31 | $14.90M 10-Q · filed 2021-05-28 | |||
| 2019-12-31 | $6.18M 10-K · filed 2022-03-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GeneDx Holdings Corp. (WGS) | United States | $2.638B | -19.23 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| Strata Critical Medical, Inc. (SRTA) | United States | $0.467B | 11.33 |
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |
| DocGo Inc. (DCGO) | United States | $0.034B | -0.25 |
| VSEE HEALTH, INC. (VSEE) | United States | $0.003B | |
| Agape ATP Corp (ATPC) | $0.002B |